英语翻译介绍About Adimab,Inc.Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover

英语翻译介绍About Adimab,Inc.Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover
英语翻译
介绍
About Adimab,Inc.
Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of
antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover high affinity antibodies that
also behave well in a formulation and manufacturing context.Our proprietary library design and presentation technology
allows us to discover full-length human antibodies with broad epitope coverage,high affinity and therapeutic relevance
faster than any current technology.
About Polaris Venture Partners
Polaris Venture Partners is a partnership of experienced private equity investors,operating executives and entrepreneurs.
The firm's mission is to identify,invest in and partner with seed,early stage,and middle market businesses with
exceptional promise and help them grow into market-leading companies.The firm has over $3 billion under management,more
than 20 investment professionals,and current investments in more than 75 companies.
About SV Life Sciences
SV Life Sciences is a venture capital fund providing financing to businesses at all stages of development across the human
life sciences sector,including biotechnology,pharmaceuticals,medical devices and instruments,and healthcare information
technology and services.SV Life Sciences currently manages or advises five funds with capital commitments of approximately
$1.6 billion.

英语翻译介绍About Adimab,Inc.Adimab is changing the discovery,maturation and production of therapeutic human antibodies.By integrating all aspects of antibody discovery and developing sophisticated screening methods,Adimab can rapidly discover
Adimab 正在变更治疗人类的抗体的发现,成熟和生产.藉由整合所有方面
抗体发现和发展中的复杂纱网材料方法,Adimab 能快速地发现高的密切关系抗体那
也很好地以一个形成和制造业上下文行为表现.我们的专有图书馆设计和发表技术
让我们用宽广的 epitope 报导发现全长的人类抗体,高密切关系和治疗的中肯
比任何的现在技术快速.
有关北极星冒险合伙人
北极星冒险合伙人是富有经验私人的公正投资者的合伙,操作主管和企业家.
公司的任务将识别,投资在并且种子,早的阶段和中央合伙在市场上销售生意由于
特别的诺言而且帮助他们发展成带领市场的公司.公司在管理之下有超过三十亿元,更多
超过 20个投资专业人士 ,和现在的投资在超过 75家公司中.
有关 SV 生活科学
SV 生活科学是冒险首都基金在整个人类的发展的所有阶段提供融资给生意
生活科学部门,包括生物科技,药学又医学的装置和器具 ,和医疗数据
技术和服务.SV 生活科学现在用首都承诺处理或者劝告五基金大约
十六亿元.